Jacquelyn W. Zimmerman

Closest collaborators

The 25 strongest of 84 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Elizabeth M. Jaffee · 12 shared papers, 2020–2026 · strength 1.65
   • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression. DOI 10.1158/0008-5472.can-24-0086↗
2. Lei Zheng · 10 shared papers, 2021–2026 · strength 1.55
   • Paper The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. DOI 10.1038/s41571-025-01077-z↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
3. Jin Peng He · 9 shared papers, 2020–2026 · strength 1.21
   • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
4. Elana Judith Fertig · 8 shared papers, 2020–2026 · strength 1.19
   • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
5. Richard Andrew Burkhart · 9 shared papers, 2020–2026 · strength 1.19
   • Paper Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospectiv… DOI 10.21037/apc-20-29↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
6. Samantha R. Guinn · 7 shared papers, 2021–2026 · strength 1.07
   • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression. DOI 10.1158/0008-5472.can-24-0086↗
7. Reecha Suri · 6 shared papers, 2020–2024 · strength 0.73
   • Paper Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospectiv… DOI 10.21037/apc-20-29↗
   • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
   • Paper Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical … DOI 10.1158/1078-0432.ccr-21-4165↗
8. Jacob T. Mitchell · 5 shared papers, 2022–2026 · strength 0.71
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
   • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
9. Christopher L. Wolfgang · 6 shared papers, 2021–2024 · strength 0.70
   • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
   • Paper Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therap… DOI 10.1097/js9.0000000000000200↗
   • Paper Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical … DOI 10.1158/1078-0432.ccr-21-4165↗
10. Luciane Tsukamoto Kagohara · 5 shared papers, 2021–2026 · strength 0.70
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
11. Toni T. Seppälä · 5 shared papers, 2020–2026 · strength 0.69
    • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical … DOI 10.1158/1078-0432.ccr-21-4165↗
12. Christopher R. Shubert · 4 shared papers, 2022–2026 · strength 0.68
    • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therap… DOI 10.1097/js9.0000000000000200↗
13. Kelly J. Lafaro · 4 shared papers, 2022–2026 · strength 0.68
    • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therap… DOI 10.1097/js9.0000000000000200↗
14. Robert A. Anders · 4 shared papers, 2020–2026 · strength 0.64
    • Paper Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics. DOI 10.1136/gutjnl-2025-335683↗
    • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
    • Paper Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Developmen… DOI 10.1158/1940-6207.capr-20-0053↗
15. Heng‐Chung Kung · 2 shared papers, 2025–2026 · strength 0.63
    • Paper The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. DOI 10.1038/s41571-025-01077-z↗
    • Paper Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics. DOI 10.1136/gutjnl-2025-335683↗
16. Benedict Kinny‐Köster · 5 shared papers, 2022–2024 · strength 0.63
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that … DOI 10.1172/jci162054↗
    • Paper Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therap… DOI 10.1097/js9.0000000000000200↗
17. Daniel J. Zabransky · 4 shared papers, 2021–2026 · strength 0.59
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression. DOI 10.1158/0008-5472.can-24-0086↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
18. David Tsai Ting · 5 shared papers, 2020–2024 · strength 0.58
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Strom… DOI 10.1158/1078-0432.ccr-23-3841↗
    • Paper Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical … DOI 10.1158/1078-0432.ccr-21-4165↗
19. William Reece Burns · 3 shared papers, 2021–2026 · strength 0.52
    • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplet… DOI 10.1080/2162402x.2021.2001159↗
20. Won Jin Ho · 3 shared papers, 2021–2026 · strength 0.45
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
    • Paper Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplet… DOI 10.1080/2162402x.2021.2001159↗
21. David P. Ryan · 4 shared papers, 2020–2024 · strength 0.45
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical … DOI 10.1158/1078-0432.ccr-21-4165↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗
22. Norman G. Nicolson · 2 shared papers, 2026 · strength 0.43
    • Paper Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcin… DOI 10.1097/sla.0000000000006517↗
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
23. Dimitrios N. Sidiropoulos · 3 shared papers, 2022–2025 · strength 0.41
    • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗
24. Laura DeLong Wood · 3 shared papers, 2022–2024 · strength 0.39
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Morphology-guided transcriptomic analysis of human pancreatic cancer organoids reveals microenvironmental signals that … DOI 10.1172/jci162054↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗
25. Jun Yu · 3 shared papers, 2022–2024 · strength 0.38
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therap… DOI 10.1097/js9.0000000000000200↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.